Johnson & Johnson

US tech giant Microsoft raises USD8 billion in combined dollars-euros bond offering

Washington-based tech company Microsoft Corp sold a record offering of USD8 billion of bonds in dollars and euros to fund general corporate purposes, according to regulatory filings today.

Read Full Article

Johnson & Johnson raises USD3.5 billion in six-part bond sale

Top credit ranking Johnson & Johnson reportedly sold USD3.5 billion in a six-part bond issue, its first offering in the last two years. Proceeds from the deal will be used to pay the health care product manufacturer's outstanding debt.

Read Full Article

Mylan, two Indian firms race to buy Bafna Pharma

US-based generic drug manufacturer Mylan and two Indian pharmaceutical firms are in talks to buy Chennai-based Bafna Pharmaceuticals for an undisclosed amount, according to two sources familiar with the transaction.

Read Full Article

Three bidders remain for Johnson & Johnson's diagnostic unit- sources

Only three potential buyers from at least five who expressed initial interest were left to bid for the Ortho Clinical Diagnostics business of healthcare firm Johnson & Johnson, according to sources interviewed by Bloomberg.

Read Full Article

Johnson & Johnson selects two bidders for diagnostics unit sale

Sources name the Carlyle Group LP and a combined group from Danaher Corp and Blackstone Group LP to have successfully advanced to the final stage of sale negotiations for J&J's diagnostics unit

Read Full Article

Bidding for J&J's Ortho Clinical Diagnostics unit heats up

Many private equity firms and partnerships are in the process of formulating their bids for diagnostic unit of Johnson&Johnson.

Read Full Article

J&J receives private equity offers

Johnson & Johnson received numerous preliminary offers from hedge funds interested in acquiring its Ortho Clinical Diagnostics unit, said a Reuters report.

Read Full Article

Sources: J&J puts clinical diagnostics unit on sale

Johnson & Johnson had launched a sale process for its Ortho Clinical Diagnostics unit valued at USD5 billion.

Read Full Article

Energizer set to acquire Johnson & Johnson feminine care brands

Energizer Holdings planned to acquire Johnson & Johnson's feminine care line for US$185 million.

Read Full Article

Kinetic Concepts acquires Systagenix

Kinetic Concepts Inc. revealed that they had signed an investment agreement to acquire Systagenix for US$485 million.

Read Full Article

CVRx gets US $29.6 million funding

The privately held company gets deal with Johnson & Johnson Development Corporation and New Enterprise Associates as co-lead investors.

Read Full Article

J&J Engages in US$1 Billion Deal to Boost Prostate Cancer Treatment

Johnson & Johnson announced that it would pay US$1 billion to Aragon Pharmaceuticals and its experimental drugs for prostate cancer treatment.

Read Full Article

Elan to sell off itself

Elan Pharmaceuticals has decided to sell itself after the many tendered offers it has received.

Read Full Article
1 2

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics